Search Within

Rona Denit Yaeger

Formats
  1. Meeting Abstract (166)
  2. Journal Article (143)
  3. Review (7)
  4. Editorial (6)
  5. Research Letter (4)
  6. Book Section (1)
  7. Correspondence (1)
  8. Guidelines (1)
Groups
  1. Department of Medicine (329)
  2. Gastrointestinal Oncology Service (329)
  3. Solid Tumor Oncology Division (329)
  4. Center for Pancreatic Cancer Research (136)
  5. GSK Faculty (134)
  6. Department of Pathology and Laboratory Medicine (125)

More Groups

People
  1. Andrea Cercek Hanjis (95)
  2. Leonard Saltz (81)
  3. Jinru Shia (76)
  4. Martin Weiser (64)
  5. Zsofia Stadler (62)
  6. Julio Garcia Aguilar (61)

More People

Years
  1. 2025 (29)
  2. 2024 (41)
  3. 2023 (37)
  4. 2022 (39)
  5. 2021 (36)
  6. 2020 (28)

More Years

Publications
  1. Journal of Clinical Oncology (101)
  2. Annals of Oncology (37)
  3. Clinical Cancer Research (17)
  4. Cancer Research (15)
  5. Cancer Discovery (14)
  6. Nature Medicine (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (111)
  2. American Association for Cancer Research (51)
  3. Oxford University Press (48)
  4. Nature Publishing Group (26)
  5. Elsevier Inc. (19)
  6. Springer (10)

More Publishers

Results (329)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BREAKWATER safety lead-in (SLI): Encorafenib + cetuximab (EC) ± chemotherapy for first-line (1L) treatment (tx) of BRAF V600E-mutant (BRAF(V600E)) metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Kopetz, S.; Yoshino, T.; Kim, T. W.; Desai, J.; Yaeger, R.; Van Cutsem, E.; Ciardiello, F.; Wasan, H. S.; Maughan, T.; Zhang, Y.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase 1b study of sotorasib, a specific and irreversible KRAS(G12C) inhibitor, in combination with other anticancer therapies in advanced colorectal cancer (CRC) and other solid tumors (CodeBreaK 101)
    Meeting Abstract

    Hong, D. S.; Yaeger, R.; Kuboki, Y.; Masuishi, T.; Barve, M. A.; Falchook, G. S.; Govindan, R.; Sohal, D.; Kasi, P. M.; Burns, T. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • KRYSTAL-1: Updated activity and safety of adagrasib (MRTX849) in patients (Pts) with unresectable or metastatic pancreatic cancer (PDAC) and other gastrointestinal (GI) tumors harboring a KRAS(G12C) mutation
    Meeting Abstract

    Bekaii-Saab, T. S.; Spira, A. I.; Yaeger, R.; Buchschacher, G. L.; McRee, A. J.; Sabari, J. K.; Johnson, M. L.; Barve, M. A.; Hafez, N.; Velastegui, K.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Same-cell co-occurrence of RAS hotspot and BRAF V600E mutations in treatment-naive colorectal cancer
    Journal Article

    Gularte-Mérida, R.; Smith, S.; Bowman, A. S.; da Cruz Paula, A.; Chatila, W.; Bielski, C. M.; Vyas, M.; Borsu, L.; Zehir, A.; Martelotto, L. G.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Immune biomarkers and response to checkpoint inhibition of BRAF(V600) and BRAF non-V600 altered lung cancers
    Journal Article

    Murciano-Goroff, Y. R.; Pak, T.; Mondaca, S.; Flynn, J. R.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Plodkowski, A. J.; Wu, S. L.; Kris, M. G.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • A comprehensive comparison of early-onset and average-onset colorectal cancers
    Journal Article

    Cercek, A.; Chatila, W. K.; Yaeger, R.; Walch, H.; Dos Santos Fernandes, G.; Krishnan, A.; Palmaira, L.; Maio, A.; Kemel, Y.; Srinivasan, P.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • EGFR amplification in metastatic colorectal cancer
    Journal Article

    Randon, G.; Yaeger, R.; Hechtman, J. F.; Manca, P.; Fucà, G.; Walch, H.; Lee, J.; Élez, E.; Seligmann, J.; Mussolin, B.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • Tumor-infiltrating lymphocytes, tumor mutational burden, and genetic alterations in microsatellite unstable, microsatellite stable, or mutant POLE/POLD1 colon cancer
    Journal Article

    Keshinro, A.; Vanderbilt, C.; Kim, J. K.; Firat, C.; Chen, C. T.; Yaeger, R.; Ganesh, K.; Segal, N. H.; Gonen, M.; Shia, J.; more...
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: Insights from the BEACON CRC study
    Review

    Tabernero, J.; Velez, L.; Trevino, T. L.; Grothey, A.; Yaeger, R.; Van Cutsem, E.; Wasan, H.; Desai, J.; Ciardiello, F.; Yoshino, T.; more...
    ESMO Open (2021)

    Fulltext@MSK | Save